Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Help & Advice
University of Warwick

The Library

  • Login
  • Admin

British Association of dermatologists guidelines for biologic therapy for psoriasis 2020 – a rapid update

Tools
- Tools
+ Tools

Smith, C. H., Yiu, Z. Z. , Bale, T., Burden, A. D., Coates, L. C., Edwards, W., MacMahon, E., Mahil, S., McGuire, A., Murphy, R., Nelson‐Piercy, C., Owen, C. M., Parslew, R., Uthman, Olalekan A., Woolf, R.T., Manounah, L., Ezejimofor, M. C., Exton, L. S. and Mohd Mustapa, M. F. (2020) British Association of dermatologists guidelines for biologic therapy for psoriasis 2020 – a rapid update. British Journal of Dermatology . doi:10.1111/bjd.19039 (In Press)

[img]
Preview
PDF
WRAP-British-Association-dermatologists-guidelines-biologic-therapy-psoriasis-Uthman-2020.pdf - Published Version - Requires a PDF viewer.
Available under License Creative Commons Attribution 4.0.

Download (715Kb) | Preview
[img] PDF
WRAP-British-Association-dermatologists-guidelines-biologic-therapy-psoriasis-Uthman-2020.pdf - Accepted Version
Embargoed item. Restricted access to Repository staff only - Requires a PDF viewer.

Download (11Mb)
Official URL: http://dx.doi.org/10.1111/bjd.19039

Request Changes to record.

Abstract

The overall aim of the guideline is to provide up‐to‐date, evidence‐based recommendations on the use of biologic therapies targeting TNF (adalimumab, etanercept, certolizumab pegol, infliximab), IL12/23p40 (ustekinumab), IL17A (ixekizumab, secukinumab), IL17RA (brodalumab) and IL23p19 (guselkumab, risankizumab, tildrakizumab) in adults, children and young people for the treatment of psoriasis; consideration is given to the specific needs of people with psoriasis and psoriatic arthritis.

Item Type: Journal Article
Subjects: R Medicine > RL Dermatology
R Medicine > RM Therapeutics. Pharmacology
Divisions: Faculty of Medicine > Warwick Medical School > Health Sciences
Faculty of Medicine > Warwick Medical School
Library of Congress Subject Headings (LCSH): Dermatologists, Psoriasis, Therapeutics
Journal or Publication Title: British Journal of Dermatology
Publisher: Wiley-Blackwell Publishing Ltd.
ISSN: 0007-0963
Official Date: 18 March 2020
Dates:
DateEvent
18 March 2020Available
18 March 2020Accepted
Date of first compliant deposit: 12 June 2020
DOI: 10.1111/bjd.19039
Status: Peer Reviewed
Publication Status: In Press
Access rights to Published version: Open Access
RIOXX Funder/Project Grant:
Project/Grant IDRIOXX Funder NameFunder ID
UNSPECIFIEDNIHR Imperial Biomedical Research Centrehttp://dx.doi.org/10.13039/501100013342
Contributors:
ContributionNameContributor ID
Research GroupThe British Association of Dermatologists’ Clinical Standards, UNSPECIFIED

Request changes or add full text files to a record

Repository staff actions (login required)

View Item View Item
twitter

Email us: wrap@warwick.ac.uk
Contact Details
About Us